NDC 50436-0188

Naproxen 250 mg tablet

On the label: Unit Dose Services. It's a repackaged product: Unit Dose Services rebottles it from Glenmark Pharmaceuticals Inc., USA's NDC 68462-188.

Where the pills inside were made

Goa, India · makes it and tests it

Problems found, fixed voluntarily Last FDA inspection Jun 30, 2026. 7 inspections on record, 1 with serious problems.

Mar 13, 2025 · Class II · Ongoing
CGMP Deviations
Lots: Lot # 17231956, exp. date Aug-25
Nov 7, 2023 · Class II · Ongoing
Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen
Lots: Lot# 19231903; Exp 4/2025 Lot# 19231858; Exp 4/2025 Lot# 19231881; Exp 4/2025 Lot# 19233484: Exp 8/2025 Lot# 19233490; Exp 8/2025
Aug 27, 2021 · Class II · Terminated
CGMP Deviations
Lots: Lots: 29190087 Exp. 10/31/2021; 29190088 Exp. 10/31/2021; 29190089 Exp. 10/31/2021; 29200077 Exp. 11/30/2022; 29200078 Exo, 11/30/2022
Aug 27, 2021 · Class II · Terminated
CGMP Deviations
Lots: Lots: a) 29190082 Exp. 09/30/2021; 29190083 Exp. 09/30/2021; 29190084 Exp. 10/31/2021; 29190085 Exp. 10/31/2021; 29200001 Exp. 12/31/2021; 29200003 Exp. 01/31/2022; 29200004 Exp. 01/31/2022; 29200005 Exp. 01/31/2022; 29200012 Exp. 02/28/2022; 29200013 Exp. 02/28/2022; b) 29200010 Exp. 02/28/2022
Jul 6, 2012 · Class II · Terminated
Labeling: Label Mix-Up: Bottles labeled as Naproxen Tablets USP, 500 mg, 100-count may contain 90-count Pravastatin Sodium Tablets, 40 mg.
Lots: Lot #: 02112930, 02112934, 02112941, Exp 09/14; 2112985, 02112986, 02113334, Exp 10/14; 02113360, 02113372, 02113420, 02113606, 02113663, 02113664, Exp 11/14.

Generic drug: Naproxen: see every company that makes it
Form: tablet
Strength: 250 mg
Approval: ANDA ANDA078250
On the market since: Jul 1, 2007
Package NDCs: 50436-0188-1 50436-0188-4
Official label: DailyMed (National Library of Medicine), updated Feb 28, 2018

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?